Literature DB >> 25517714

Multidrug-resistant tuberculosis and bedaquiline.

Andreas H Diacon, Nacer Lounis, Brian Dannemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25517714     DOI： 10.1056/NEJMc1412235

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Dual Mechanism of Action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.

Authors:  Saqib Kidwai; Chan-Yong Park; Shradha Mawatwal; Prabhakar Tiwari; Myung Geun Jung; Tannu Priya Gosain; Pradeep Kumar; David Alland; Sandeep Kumar; Avinash Bajaj; Yun-Kyung Hwang; Chang Sik Song; Rohan Dhiman; Ill Young Lee; Ramandeep Singh
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs.

Authors:  Tea Madzgharashvili; Argita D Salindri; Matthew J Magee; Nestani Tukvadze; Zaza Avaliani; Henry M Blumberg; Russell R Kempker; Nino Lomtadze
Journal:  J Pediatric Infect Dis Soc       Date:  2021-04-30       Impact factor: 3.164

3.  Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis.

Authors:  Mamta Singh; Prabhakar Tiwari; Garima Arora; Sakshi Agarwal; Saqib Kidwai; Ramandeep Singh
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

4.  Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy.

Authors:  Luigi R Codecasa; Mondher Toumi; Anna D'Ausilio; Andrea Aiello; Francesco Damele; Roberta Termini; Alessia Uglietti; Robert Hettle; Giorgio Graziano; Saverio De Lorenzo
Journal:  J Mark Access Health Policy       Date:  2017-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.